Veterinary Surgical Oncology. Группа авторов
Читать онлайн книгу.
therapy on outcome of dogs with appendicular osteosarcoma following amputation and carboplatin chemotherapy: A multi‐institutional study. PLoS One 10:e0124889.
402 London, C.A., A.L. Hannah, R. Zadovoskaya, et al. 2003. Phase I dose‐escalating study of SU11654, a small molecule receptor tyrosine kinase inhibitor, in dogs with spontaneous malignancies. Clin Cancer Res 9:2755–2768.
403 London, C.A., P.B. Malpas, S.L. Wood‐Follis, et al. 2009. Multi‐center, placebo‐controlled, double‐blind, randomized study of oral toceranib phosphate (SU11654), a receptor tyrosine kinase inhibitor, for the treatment of dogs with recurrent (either local or distant) mast cell tumor following surgical excision. Clin Cancer Res 15:3856–3865.
404 London, C., T.Mathie, N.Stingle et al. 2012. Preliminary evidence for biologic activity of toceranib phosphate (Palladia(®)) in solid tumours. Vet Comp Oncol 10(3):194–205.
405 Lori, J.C., T.J. Stein, and D.H. Thamm. 2010. Doxorubicin and cyclophosphamide for the treatment of canine lymphoma: A randomized, placebo‐controlled study. Vet Comp Oncol 8:188–195.
406 Lucas, S.R., R.C. Maranhao, J.L. Guerra, et al. 2015. Pilot clinical study of carmustine associated with a lipid nanoemulsion in combination with vincristine and prednisone for the treatment of canine lymphoma. Vet Comp Oncol 13:184–193.
407 Lucroy, M.D., M.H. Bowles, R.G. Higbee, et al. 2003a. Photodynamic therapy for prostatic carcinoma in a dog. J Vet Intern Med 17:235–237.
408 Lucroy, M.D., K.R. Long, M.A. Blaik, et al. 2003b. Photodynamic therapy for the treatment of intranasal tumors in 3 dogs and 1 cat. J Vet Intern Med 17:727–729.
409 Lucroy, M.D., T.D. Ridgway, G.M. Peavy, et al. 2003c. Preclinical evaluation of 5‐aminolevulinic acid‐based photodynamic therapy for canine transitional cell carcinoma. Vet Comp Oncol 1:76–85.
410 Lunn, K.F. and R.L. Page. 2013. 25 – Tumors of the endocrine system. In Withrow and MacEwen's Small Animal Clinical Oncology, 5th edition. R.L. Page, S.J. Withrow, and D.M. Vail, editors. St. Louis: W.B. Saunders.
411 Lurie, D.M., I.K. Gordon, A.P. Theon, et al. 2009. Sequential low‐dose rate half‐body irradiation and chemotherapy for the treatment of canine multicentric lymphoma. J Vet Intern Med 23:1064–1070.
412 MacDonald, T.L. and T.D. Schiller. 2010. Limb‐sparing surgery using tantalum metal endoprosthesis in a dog with osteosarcoma of the distal radius. Can Vet J 51:497–500.
413 MacEwan, E.P., B.E. Powers, and D. Macy. 2001. Soft tissue sarcomas. In Small Animal Clinical Oncology, 3rd edition. S.J. Withrow, editor. Philadelphia: WB Saunders.
414 MacEwen, E.G., N.O. Brown, A.K. Patnaik, et al. 1981. Cyclic combination chemotherapy of canine lymphosarcoma. J Am Vet Med Assoc 178:1178–1181.
415 MacEwen, E.G., A.A. Hayes, R.E. Matus, et al. 1987. Evaluation of some prognostic factors for advanced multicentric lymphosarcoma in the dog: 147 cases (1978–1981). J Am Vet Med Assoc 190:564–568.
416 MacEwen, E.G., A.A. Hayes, S. Mooney, et al. 1985. Levamisole as adjuvant to chemotherapy for canine lymphosarcoma. J Biol Response Mod 4:427–433.
417 MacEwen, E.G. and A.I. Hurvitz. 1977. Diagnosis and management of monoclonal gammopathies. Vet Clin North Am 7:119–132.
418 MacEwen, E.G., I.D. Kurzman, D.M. Vail, et al. 1999. Adjuvant therapy for melanoma in dogs: Results of randomised clinical trials using surgery, liposome‐encapsulated muramyl tripeptide and granulocyte‐macrophage colony‐stimulating factor. Clin Cancer Res 5:42–49.
419 MacEwen, E.G., A.K. Patnaik, H.J. Harvey, et al. 1986. Canine oral melanoma: Comparison of surgery versus surgery plus Corynebacterium parvum. Cancer Invest 4:397–402.
420 Macewen, E.G., A.K. Patnaik, A.I. Hurvitz, et al. 1984. Nonsecretory multiple myeloma in two dogs. J Am Vet Med Assoc 184:1283–1286.
421 MacEwen, E.G., S.J. Withrow, and A.K. Patnaik. 1977. Nasal tumors in the dog: Retrospective evaluation of diagnosis, prognosis, and treatment. J Am Vet Med Assoc 170:45–48.
422 Macy, D.W. 1986. Canine and feline mast cell tumors: Biologic behavior, diagnosis, and therapy. Semin Vet Med Surg Small Anim 1:72–83.
423 Maglennon, G.A., S. Murphy, V. Adams, et al. 2008. Association of Ki67 index with prognosis for intermediate‐grade canine cutaneous mast cell tumours. Vet Comp Oncol 6:268–274.
424 Mahoney, J.A., P.J. Bergman, M.A. Camps‐Palau, et al. 2007. Treatment of doxorubicin extravasation with intravenous dexrazoxane in a cat. J Vet Intern Med 21:872–873.
425 Mallery, K.F., R.E. Pollard, R.W. Nelson, et al. 2003. Percutaneous ultrasound‐guided radiofrequency heat ablation for treatment of hyperthyroidism in cats. J Am Vet Med Assoc 223:1602–1607.
426 Marcinowska, A., J. Warland, M. Brearley, et al. 2013. A novel approach to treatment of lymphangiosarcoma in a boxer dog. J Small Anim Pract 54:334–337.
427 Marconato, L., P. Frayssinet, N. Rouquet, et al. 2014. Randomized, placebo‐controlled, double‐blinded chemoimmunotherapy clinical trial in a pet dog model of diffuse large B‐cell lymphoma. Clin Cancer Res 20:668–677.
428 Marconato, L., R.M. Lorenzo, F. Abramo, et al. 2008. Adjuvant gemcitabine after surgical removal of aggressive malignant mammary tumours in dogs. Vet Comp Oncol 6:90–101.
429 Marconato, L., V. Martini, D. Stefanello, et al. 2015a. Peripheral blood lymphocyte/monocyte ratio as a useful prognostic factor in dogs with diffuse large B‐cell lymphoma receiving chemoimmunotherapy. Vet J 206:226–230.
430 Marconato, L., D.B. Nitzl, K.J. Melzer‐Ruess, et al. 2012. Chemotherapy and radiation therapy in 4 dogs with muscle‐invasive transitional cell carcinoma of the urinary tract. Can Vet J 53:875–879.
431 Marconato, L., D. Stefanello, S. Sabattini, et al. 2015b. Enhanced therapeutic effect of Apavac immunotherapy in combination with dose‐intense chemotherapy in dogs with advanced indolent B‐cell lymphoma. Vaccine 33:5080–5086.
432 Marconato, L., E. Zini, D. Lindner, et al. 2011. Toxic effects and antitumor response of gemcitabine in combination with piroxicam treatment in dogs with transitional cell carcinoma of the urinary bladder. J Am Vet Med Assoc 238:1004–1010.
433 Marino, D.J., J.M. MacDonald, D.T. Matthiesen, et al. 1993. Results of surgery and long‐term follow‐up in dogs with ceruminous gland adenocarcinoma. J Am Anim Hosp Assoc 29:560–563.
434 Marino, D.J., J.M. MacDonald, D.T. Matthiesen, et al. 1994. Results of surgery in cats with ceruminous gland adenocarcinoma. J Am Anim Hosp Assoc 30:54–58.
435 Marks, S. 2001. Update on canine and feline gastrointestinal neoplasia. In 26th World Small Animal Veterinary Association World Congress, Vancouver, BC.
436 Martin, R.A., E.W. Evans, J.R. August, et al. 1986. Surgical treatment of a thymoma in a cat. J Am Anim Hosp Assoc 22:347–354.
437 Maruo, T., T. Shida, Y. Fukuyama, et al. 2011. Retrospective study of canine nasal tumor treated with hypofractionated radiotherapy. J Vet Med Sci 73:193–197.
438 Marvel, S.J., B. Seguin, D.D. Dailey, et al. 2017. Clinical outcome of partial cystectomy for transitional cell carcinoma of the canine bladder. Vet Comp Oncol 15:1417–1427.
439 Matsuyama, A., C.R. Schott, G.A. Wood, et al. 2018. Evaluation of metronomic cyclophosphamide chemotherapy as maintenance treatment for dogs with appendicular osteosarcoma following limb amputation and carboplatin chemotherapy. J Am Vet Med Assoc 252(11):1377–1383.
440 Matus, R.E., C.E. Leifer, E.G. MacEwen, et al. 1986. Prognostic factors for multiple myeloma in the dog. J Am Vet Med Assoc 188:1288–1292.
441 Mauldin, G.N., R.E. Matus, A.K. Patnaik, et al. 1988a. Efficacy and toxicity of doxorubicin and cyclophosphamide used in the treatment of selected malignant tumors in 23 cats. J Vet Intern Med 2:60–65.
442 Mauldin, G.N., R.E. Matus, S.J. Withrow, et al. 1988b. Canine osteosarcoma. Treatment by amputation versus amputation and adjuvant chemotherapy using doxorubicin and cisplatin. J Vet Intern Med 2:177–180.
443 Mayhew,